From 3 February 2025, the respiratory syncytial virus (RSV) vaccine Abrysvo will be available under the National Immunisation Program (NIP) for eligible pregnant women. Pharmacists can administer Abrysvo to pregnant women between 28 and 36 weeks of pregnancy to reduce the risk of severe RSV disease …
